The depletion of T cells from haematopoietic stem cell transplants

Rheumatology

Volumn 38, Issue 8, 1999, Pages 751-754

  Slaper Cortenbach, I C M ^e,f   Wijngaarden du Bois, M J G J ^e   De Vries van Rossen, A ^e   Borst, H P E ^e   Van Der Lelie, H ^a   Van Heugten, H G ^b   Verdonck, L F ^b   Wulffraat, N M ^c   Hoogerbrugge, P M ^d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f CENTRAL LABORATORY   (Netherlands)

Author keywords

Depletion; Haematopoietic stem cell transplants; T cells

Indexed keywords

MONOCLONAL ANTIBODY;

CELL SEPARATION; CONFERENCE PAPER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; JUVENILE RHEUMATOID ARTHRITIS; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TECHNIQUE;

ANTIGENS, CD2; ANTIGENS, CD3; ANTIGENS, CD34; ARTHRITIS, JUVENILE RHEUMATOID; BONE MARROW CELLS; CHILD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOCYTE DEPLETION; T-LYMPHOCYTES; TRANSPLANTATION CONDITIONING;

EID: 0032732330     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.8.751     Document Type: Conference Paper

References (12)

1. Kernan NA, Collins NH, Juliano L, Cartagena T, Dupont B, O'Reilly RJ. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood 1986;68:770-3.
2. Schattenberg A, Preijers F, Mensink E, Bar B, Schaap N, Geurts-van Kessel A et al. Survival in first or second remission after lymphocyte depleted transplantation for Philadelphia chromosome-positive CML in first chronic phase. Bone Marrow Transplant 1997;19:1205-12.
3. Hale G, Waldmann H. Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant disease. Bone Marrow Transplant 1994;13:597-611.
4. Lansdorp PM, Aalberse RC, Bos R, Schutter WG, Van Bruggen EF. Cyclic tetramolecular complexes of monoclonal antibodies: a new type of cross-linking reagent. Eur J Immunol 1986;16:679-83.
5. Slaper-Cortenbach ICM, Admiraal LG, van Leeuwen EF, Kerr JM, von dem Borne AE, Tetteroo P. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis. Exp Hematol 1990;18: 49-54.
6. Richel D, Johnsen H, Canon J, Schaafsma M, Schenkeveld C, Hansen S et al. Highly purified CD34+ cells isolated with the Amgen cell selector provide rapid engraftment following high dose chemotherapy in breast cancer patients. Blood 1996;88:110a.
7. Van Bekkum DW. Perspectives in hematology. Autologous stem cell therapy for treatment of autoimmune diseases. Exp Hematol 1998;26:831-4.
8. van Bekkum DW. Effectiveness and risks of total body irradiation for conditioning in the treatment of autoimmune disease with autologous bone marrow transplantation. Rheumatology 1999;38:757-61.
9. Wulffraat NM, Kuis W. Autologous stem cell transplantation: a possible treatment for refractory juvenile chronic arthritis? Rheumatology 1999;38:764-6.
10. Verdonck LF, de Gast CG, van Heugten HG, Dekker AW. A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantation. Blood 1990; 75:776-80.
11. Stainer CJ, Miflin G, Anderson S, Davy B, McQuaker IG, Russell NH. A comparison of two different systems for CD34 selection of autologous or allogeneic PBSC collections. J Hematother 1998;7:375-83.
12. Kwekkeboom J, Buurman DEP, Ploemacher RE, Baars JW, Loos HA, Slaper-Cortenbach ICM. A filter of nylon wool coated with human immunoglobulin for rapid depletion of monocytes and myeloid cells from peripheral blood stem cell transplants. Exp Hematol 1998;26:400-8.